Cargando…
Sex-associated molecular differences for cancer immunotherapy
Immune checkpoint blockade therapies have extended patient survival across multiple cancer lineages, but there is a heated debate on whether cancer immunotherapy efficacy is different between male and female patients. We summarize the existing meta-analysis to show inconsistent conclusions for wheth...
Autores principales: | Ye, Youqiong, Jing, Ying, Li, Liang, Mills, Gordon B., Diao, Lixia, Liu, Hong, Han, Leng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156379/ https://www.ncbi.nlm.nih.gov/pubmed/32286310 http://dx.doi.org/10.1038/s41467-020-15679-x |
Ejemplares similares
-
Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy
por: Jing, Ying, et al.
Publicado: (2020) -
The genetic and pharmacogenomic landscape of snoRNAs in human cancer
por: Liu, Yaoming, et al.
Publicado: (2020) -
Profiling of immune features to predict immunotherapy efficacy
por: Ye, Youqiong, et al.
Publicado: (2021) -
APAatlas: decoding alternative polyadenylation across human tissues
por: Hong, Wei, et al.
Publicado: (2020) -
Characterization of intratumor microbiome in cancer immunotherapy
por: Zhang, Zhao, et al.
Publicado: (2023)